TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive In Brief: Health Chief Defends Cancer Program, Corrects The Record On NCI, NIH Support Of Basic Research January 24, 1975
